Open AccessSystematic Review of Contemporary Evidence for the Management of T1 Renal Cell Carcinoma: What IRs Need to Know for Kidney Cancer Tumor Boards
Author(s) -
J. Cronan,
Sean R. Dariushnia,
Z. Bercu,
R. Ermentrout,
Bill S. Majdalany,
Laura Findeiss,
Janice Newsome,
Nima Kokabi
Publication year - 2019
Publication title -
seminars in interventional radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.35
H-Index - 40
eISSN - 1098-8963
pISSN - 0739-9529
DOI - 10.1055/s-0039-1693119
Subject(s) - medicine , renal cell carcinoma , malignancy , kidney cancer , epidemiology , specialty , cancer , kidney , intensive care medicine , review article , oncology , pathology
Renal cell carcinoma is a relatively common malignancy, with 60 to 70 thousand cases a year in the United States alone. Increased utilization of cross-sectional imaging has led to an increase in the number of early renal cell cancers seen by the medical establishment. In addition, certain patient populations have an increased risk of developing kidney cancers which may mandate aggressive screening protocols. This article discusses the epidemiology of renal cell cancers; discusses the current management guidelines from multiple specialty societies; discusses some of the surgical and interventional techniques used in the treatment of such lesions; and provides a review of the literature regarding treatments of early-stage renal cell cancers.